Patient Representative - Birmingham Trial Management Group for new phase II Colorectal Cancer Trial
Share your experience of colorectal cancer to help us develop a new early-phase clinical trial. As a patient representative of the Trial Management Group, your experience and thoughts can help to develop a clinical trial that is relevant and impactful for future patients.
Closing date for applications: Friday 23rd February
Time commitment: The group will aim to meet every 3 months
Location: University of Birmingham
Any specific criteria: We'd like to hear from people affected by colorectal cancer
Expenses: We'll cover reasonable travel expenses to attend the meetings, so this opportunity may be more suited to those living in the West Midland area.
About the opportunity
We're looking to recruit two people affected by colorectal cancer to help develop and manage a new early-phase trial in colorectal cancer. The ANICCA – Class II clinical trial will determine the clinical benefit of the immunotherapy agent Nivolumab in patients with high class II expression microsatellite stable colorectal cancer (MSS CRC). As a member of the Trial Management Group, you will work closely with the trial team at the Cancer Research UK Clinical Trials Unit, University of Birmingham to develop and monitor this exciting new trial.
The main purpose of this role is to help with the content and development of the patient related documents. This will include a patient information sheet and materials used to promote the trial to patients. Your experience will be invaluable when considering recruitment strategies and how to promote the clinical trial.
This clinical trial is in the early stages of being developed so provides a fantastic opportunity to get involved and follow through the progression of a clinical trial.
To join the group please contact Ben Watkins (Trial Coordinator) on 0121 415 8544 for an informal discussion. Or email us on the link below.